Atomo Diagnostics Limited (ASX:AT1)
0.0350
-0.0040 (-10.26%)
At close: Mar 9, 2026
Atomo Diagnostics Revenue
Atomo Diagnostics had revenue of 2.18M AUD in the half year ending December 31, 2025, with 13.37% growth. This brings the company's revenue in the last twelve months to 3.92M, down -7.00% year-over-year. In the fiscal year ending June 30, 2025, Atomo Diagnostics had annual revenue of 3.79M, down -7.20%.
Revenue (ttm)
3.92M
Revenue Growth
-7.00%
P/S Ratio
7.23
Revenue / Employee
46.12K
Employees
85
Market Cap
28.36M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CurveBeam AI | 12.15M |
| ImpediMed | 14.23M |
| Control Bionics | 6.07M |
| CleanSpace Holdings | 20.66M |
| Nova Eye Medical | 33.05M |
| HeraMED | 431.61K |
| Micro-X | 16.90M |
| CONNEQT Health | 5.80M |
Atomo Diagnostics News
- 6 months ago - Atomo Diagnostics Ltd (ASX:AT1) Full Year 2025 Earnings Call Highlights: Navigating Challenges ... - GuruFocus